Mineralys Therapeutics's three largest insider shareholders as of May 22, 2026 are Brian Taylor Slingsby (Director, 7.91Mn shares), Brian Taylor Slingsby (Director, 7.91Mn shares), Brian Taylor Slingsby (Director, 7.91Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Brian Taylor Slingsby | - | 0 | 7,910,038 | 20 Feb, 2026 |
| Brian Taylor Slingsby | - | 0 | 7,903,838 | 21 Nov, 2025 |
| Capital Management, L.P. Ra | - | 0 | 5,825,521 | 31 Mar, 2026 |
| Srinivas Akkaraju | - | 0 | 5,674,916 | 17 Mar, 2025 |
| Biocapital Gp, Llc Samsara | - | 0 | 5,674,916 | 17 Mar, 2025 |
| Srinivas Akkaraju | - | 0 | 5,074,916 | 14 Feb, 2024 |
| Biocapital Gp, Llc Samsara | - | 0 | 5,074,916 | 14 Feb, 2024 |
| Healthcare Investments (Cayman) Ltd. Hbm | - | 3,218,106 | 0 | 16 Feb, 2023 |
| Capital Management, L.P. Ra | - | 0 | 2,983,755 | 14 Feb, 2024 |
| Jon Congleton | Chief Executive Officer | 705,051 | 0 | 02 Apr, 2026 |
| Jon Congleton | Chief Executive Officer | 689,321 | 0 | 15 Apr, 2026 |
| Srinivas Akkaraju | - | 0 | 588,235 | 08 Sep, 2025 |
| David Malcom Rodman | Chief Medical Officer | 69,792 | 0 | 21 Apr, 2026 |
| Adam Scott Levy | Cfo And Secretary | 48,538 | 0 | 20 Feb, 2026 |
| Alexander M Gold | - | 6,200 | 0 | 20 Feb, 2026 |
| Daphne Karydas | - | 6,200 | 0 | 02 Apr, 2026 |
| Glenn Sblendorio | - | 6,200 | 0 | 20 Feb, 2026 |
| Derek Dirocco | - | 6,200 | 0 | 20 Feb, 2026 |
| Srinivas Akkaraju | - | 6,200 | 0 | 20 Feb, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 17 Apr, 2026 | David Malcom Rodman | Common Stock | A | 416 | $15.44 | 70,208 | D | M |
| 17 Apr, 2026 | David Malcom Rodman | Common Stock | A | 416 | $15.44 | 70,208 | D | M |
| 17 Apr, 2026 | David Malcom Rodman | Common Stock | D | 416 | $31.33 | 69,792 | D | S |
| 17 Apr, 2026 | David Malcom Rodman | Common Stock | D | 416 | $31.33 | 69,792 | D | S |
| 17 Apr, 2026 | David Malcom Rodman | Stock Option | D | 416 | $0.00 | 4,584 | D | M |
| 17 Apr, 2026 | David Malcom Rodman | Stock Option | D | 416 | $0.00 | 4,584 | D | M |
| 13 Apr, 2026 | David Malcom Rodman | Common Stock | A | 6,349 | $1.08 | 82,489 | D | M |
| 13 Apr, 2026 | David Malcom Rodman | Common Stock | A | 6,349 | $1.08 | 82,489 | D | M |
| 13 Apr, 2026 | Jon Congleton | Common Stock | D | 15,730 | $26.83 | 689,321 | D | S |
| 13 Apr, 2026 | David Malcom Rodman | Common Stock | A | 6,349 | $1.08 | 82,489 | D | M |
| 13 Apr, 2026 | David Malcom Rodman | Common Stock | A | 3,542 | $10.20 | 86,031 | D | M |
| 13 Apr, 2026 | David Malcom Rodman | Common Stock | A | 3,542 | $10.20 | 86,031 | D | M |
| 13 Apr, 2026 | David Malcom Rodman | Common Stock | A | 3,542 | $10.20 | 86,031 | D | M |
| 13 Apr, 2026 | David Malcom Rodman | Common Stock | A | 4,167 | $14.25 | 90,198 | D | M |
| 13 Apr, 2026 | David Malcom Rodman | Common Stock | A | 4,167 | $14.25 | 90,198 | D | M |
| 13 Apr, 2026 | David Malcom Rodman | Common Stock | A | 4,167 | $14.25 | 90,198 | D | M |
| 13 Apr, 2026 | David Malcom Rodman | Common Stock | D | 14,058 | $26.54 | 76,140 | D | S |
| 13 Apr, 2026 | David Malcom Rodman | Common Stock | D | 14,058 | $26.54 | 76,140 | D | S |
| 13 Apr, 2026 | David Malcom Rodman | Common Stock | D | 14,058 | $26.54 | 76,140 | D | S |
| 15 Apr, 2026 | David Malcom Rodman | Common Stock | D | 6,348 | $27.66 | 69,792 | D | S |